The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The RNA Targeting Small Molecules Therapeutics Market In 2026 And What Value Is Projected For 2030?
The rna targeting small molecules therapeutics market size has experienced significant expansion in recent years. This market is projected to expand from $2.93 billion in 2025 to $3.1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.8%. Historically, this growth can be linked to factors such as the restricted effectiveness of protein-targeted drugs, increased funding for genomic research, the rising incidence of cancer and genetic disorders, initial breakthroughs in rna-based therapies, and the proliferation of collaborations between academia and industry.
The rna targeting small molecules therapeutics market is projected to experience substantial growth over the next few years. It is forecast to expand to $4.84 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.7%. This anticipated growth throughout the forecast period stems from factors such as advancements in RNA structure prediction, increasing demand for precision therapeutics, a rise in biotech investments focused on small molecules, supportive regulatory environments for novel RNA drugs, and an expanding pipeline of RNA-targeting clinical trials. Significant trends for the forecast period include the broadening of RNA-targeted drug pipelines, a concentrated effort on disease targets previously deemed undruggable, enhanced collaborations between pharmaceutical and biotechnology companies, progress in RNA structural biology and chemistry, and an increase in investment for therapies addressing rare and genetic diseases.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12253&type=smp
What Major Drivers Are Influencing Demand In The RNA Targeting Small Molecules Therapeutics Market?
The increasing number of cancer cases is expected to propel the growth of the RNA-targeting small molecule therapeutics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Cancer is treated with RNA-targeting small molecules created and investigated to target RNA molecules associated with cancer selectively. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases are projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing number of cancer cases is driving the growth of the RNA-targeting small molecule therapeutics market. The rising incidence of genetic disorders is expected to boost the growth of the RNA-targeting small-molecule therapeutics market going forward. Genetic disorders are conditions caused by abnormalities or mutations in an individual’s genetic material, such as DNA or chromosomes. RNA-targeting small-molecule therapeutics are an exciting emerging field with immense potential for treating genetic disorders. Some genetic disorders involve toxic expansions of repeated RNA sequences. Small molecules can stabilize or destabilize these expansions, potentially mitigating their harmful effects. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based national charity, there were 11,148 people living with cystic fibrosis (CF) in the UK in 2022, increasing to 11,318 in 2023. Therefore, the rising incidence of genetic disorders is driving the growth of the RNA-targeting small-molecule therapeutic market.
What Are The Key Segments Of The RNA Targeting Small Molecules Therapeutics Market?
The rna targeting small molecules therapeutics market covered in this report is segmented –
1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings
2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications
3) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
What Key Trends Are Influencing The Development Of The RNA Targeting Small Molecules Therapeutics Market?
Leading entities within the RNA-targeting small molecule therapeutics market are prioritizing the establishment of strategic alliances to boost the innovation and advancement of new treatments. These collaborations typically involve multiple organizations uniting their specialized knowledge, sharing crucial data, and speeding up the generation of cutting-edge RNA-targeting small molecules. For example, June 2022 saw Otsuka Pharmaceutical Co. Ltd., a pharmaceutical manufacturing firm based in Japan, enter into a collaboration with xFOREST Therapeutics Co. Ltd., a Japan-based developer of drug discovery platforms. Through this alliance, xFOREST committed to providing Otsuka with its proprietary Forest technology to further systemic small-molecule drug discovery research specifically targeting RNA structures. Additionally, in April 2024, Ipsen, a biopharmaceutical company from France, joined forces with Skyhawk Therapeutics, a US-based clinical-stage biotechnology firm specializing in RNA-targeting small molecule therapeutics. This cooperative effort allowed Ipsen to focus on creating RNA-targeting small molecule drugs for rare neurological conditions, by integrating diverse data sets to pinpoint and formulate small molecules capable of modulating RNA.
Who Are The Leading Companies Operating In The RNA Targeting Small Molecules Therapeutics Market?
Major companies operating in the rna targeting small molecules therapeutics market are F Hoffmann La Roche Ltd, Novartis AG, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Amgen Inc, Bayer AG, Vertex Pharmaceuticals Inc, PTC Therapeutics Inc, Arrakis Therapeutics, Anima Biotech Inc, Skyhawk Therapeutics Inc, Remix Therapeutics, Accent Therapeutics Inc, STORM Therapeutics Ltd, eFFECTOR Therapeutics Inc, EPICS Therapeutics, Expansion Therapeutics Inc, Ribometrix Inc, Redona Therapeutics, Eloxx Pharmaceuticals Inc, 858 Therapeutics
Read the full rna targeting small molecules therapeutics market report here:
Which Region Shows The Strongest Potential For Future Growth In The RNA Targeting Small Molecules Therapeutics Market?
North America was the largest region in the RNA targeting small molecules therapeutics market in 2025. The regions covered in the rna targeting small molecules therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored RNA Targeting Small Molecules Therapeutics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12253&type=smp
Browse Through More Reports Similar to the Global RNA Targeting Small Molecules Therapeutics Market 2026, By The Business Research Company
Rna Targeting Small Molecules Therapeutics Market Report 2026
Rna Targeting Small Molecule Drug Discovery Market Report 2026
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model